Endophthalmitis as a Serious Complication of Intravitreal Drug Delivery

被引:1
|
作者
Lommatzsch, A. P. [1 ]
Bartels, S. [1 ]
Heimes, B. [1 ]
Spital, G. [1 ]
Dietzel, M. [1 ]
Freistuehler, M. [2 ]
Bornfeld, N. [2 ]
Pauleikoff, D. [2 ]
机构
[1] St Franziskus Hosp Munster, Augenabt, D-48145 Munster, Germany
[2] Univ Augenklin Essen, Essen, Germany
关键词
intravitreal injection; endophthalmitis; vitrectomy; ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; CAUSATIVE ORGANISMS; INJECTION; RANIBIZUMAB; ANTIBIOTICS; BEVACIZUMAB; TRIAMCINOLONE; PREVENTION; STRATEGIES;
D O I
10.1055/s-0033-1350686
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Background: Endophthalmitis, regarded as a severe complication, can occur after intraocular injection of drugs (IVI). At present only few reports exist on the development of this disease, although recently the number of intraocular injections to treat especially age-related macular degenerations is increasing considerably. Methods: In this paper we present our results of a retrospective study of 27 patients suffering from endophthalmitis after IVI. Treatment had been performed between January 2008 and March 2012. The indications for IVI were as follows: age-related macular degeneration 19, venous branch occlusion 1, diabethic retinopathies 6, uveitis 1. The following drugs were injected: bevacizumab in 8, Rranibizumab in 19 patients. The following data were assessed: incubation time, best corrected visual acuity that had been determined before treatment and later 3, 6 and 9 months after therapeutic vitrectomy. Additionally we describe the ophthalmoscopic changes and the results of bacteriological studies. Results: Endophthalmitis was diagnosed 5.8 days after IVI on average. The vision of all patients had only been hand movements during the first examination. During the observation time the postoperative visual acuity could be improved only to 1/35 on average. During vitrectomy in 24 out of 27 patients a whitish retinal infiltration could be observed. 18 of 27 patients showed a hypopyon during slit lamp examination. 11 patients developed a retinal detachment and one eye had to be enucleated. Conclusions: Endophthalmitis must be regarded as a severe complication causing a high risk of retinal detachment with permanent loss of visual acuity. Retinal infiltrations and haemorrhages occur already in the early stages and cause finally a very poor prognosis. The incubation time as a rule amounts to 6 days. The increasing number of IVI and the high risk of damaged retinal structures due to intraocular infections should make postoperative retinal follow-up examinations mandatory, especially during the first 6 days.
引用
收藏
页码:1130 / 1134
页数:5
相关论文
共 50 条
  • [1] Endophthalmitis as serious Complication of intravitreal Drug Administration
    Lang, Gerhard K.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2013, 230 (11) : 1094 - 1094
  • [2] Endophthalmitis as a serious complication of intravitreal drug delivery (vol 230, pg 1130, 2013)
    Lommatzsch, A. P.
    Bartels, S.
    Heimes, B.
    [J]. KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2018, 235 (02) : 195 - 195
  • [3] ENDOPHTHALMITIS AS A COMPLICATION OF INTRAVITREAL TREATMENT FOR CYTOMEGALOVIRUS RETINITIS
    COLLAZOS, J
    DIAZ, F
    MAYO, J
    MARTINEZ, E
    FERNANDEZ, A
    [J]. AIDS, 1995, 9 (08) : 980 - 981
  • [4] Endophthalmitis as a complication of intravitreal injection: A systemic review.
    Jager, RD
    Timothy, N
    Coney, J
    Keenan, HA
    Arrigg, P
    Aiello, LP
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U758 - U758
  • [5] Intravitreal triamcinolone acetonide. Complication of infectious and sterile endophthalmitis
    Kreissig, I
    Degenring, RF
    Jonas, JB
    [J]. OPHTHALMOLOGE, 2006, 103 (01): : 30 - 34
  • [6] GROTESQUE OBESITY - SERIOUS COMPLICATION OF LABOR AND DELIVERY
    FREEDMAN, MA
    GEORGE, WM
    WILDS, PL
    [J]. SOUTHERN MEDICAL JOURNAL, 1972, 65 (06) : 732 - &
  • [7] Prefilled syringes for intravitreal drug delivery
    Sassalos, Therese M.
    Paulus, Yannis M.
    [J]. CLINICAL OPHTHALMOLOGY, 2019, 13 : 701 - 706
  • [8] Nanoparticles for intravitreal controlled drug delivery
    Tang, L
    Weng, H
    Zhou, J
    Hu, Z
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U486 - U486
  • [9] Intravitreal triamcinolone and endophthalmitis
    Parke, DW
    [J]. AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (05) : 918 - 919
  • [10] Intravitreal treatment of endophthalmitis
    Jacquin, C
    Nasica, X
    Guillard, D
    Aujoulat, O
    Stoeckel, C
    [J]. MEDECINE ET MALADIES INFECTIEUSES, 2001, 31 (7-8): : 493 - 497